Who are we?
Team TRANSPORT is a multidisciplinary research team in the Gemstone Honors program at UMD. We are a group of 10 undergraduate students with a diverse set of majors looking to improve the treatment of pancreatic cancer for patients.
Pancreatic cancer is one of the leading causes of cancer-related deaths. Since it is often found in later stages, treatment is expensive, invasive, and often ineffective. Team TRANSPORT is looking to incorporate nanogel technology into chemotherapeutic treatment to improve the efficacy of drug delivery for pancreatic cancer.
Typical chemotherapy programs are expensive, physically and emotionally taxing on patients, and result in a multitude of side effects including hair loss, nausea, vomiting, changes in appetite and fatigue. To combat this, our team is researching a plant-derived chemotherapeutic drug alternative called artemisinin. As it has promising anti-cancer effects, we plan to implement a nanogel-drug combination called NanoART361 to improve treatment and mitigate the toxic side effects of chemotherapeutic treatments.
Why help us?
Every year thousands of people are diagnosed with late stage pancreatic cancer. Our team's goal is to find a way to make therapies more effective, with equitable access to treatment, and improve quality of life during chemotherapy treatment. Your support will help progress our research and bring us closer to this goal. Every dollar counts!
Gifts in support of the University of Maryland are accepted and managed by the University of Maryland College Park Foundation, Inc., an affiliated 501(c)(3) organization authorized by the Board of Regents. Contributions to the University of Maryland are tax deductible as allowed by law. Please see your tax advisor for details.